Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
171.00    2.60 (1.54%)
Bid:
171.20
Ask:
171.80
Spread: 0.60 (0.35%)
Market Cap: £416.08m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Director/PDMR Shareholding

21 May 2021 14:05

RNS Number : 4807Z
Sabre Insurance Group PLC
21 May 2021
 

21 May 2021

 

Sabre Insurance Group plc ("Sabre" or the "Company")

Notification of transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

Awards under the Company's Long Term Incentive Plan

The Company announces that on 21 May 2021 the following directors and PDMRs of the Company were, subject to the rules of the Sabre 2017 Long Term Incentive Plan, each granted a conditional award (the 'LTIP Award') of ordinary shares of £0.001 in the Company as detailed below:

 

Name

Position

Number of shares subject to award

Geoff Carter

Chief Executive Officer

126,539

Anneka Kingan

Chief Risk and Officer & Company Secretary

47,638

Trevor Webb

Claims Director

78,790

Adam Westwood

Chief Financial Officer

59,548

Matt Wright

Chief Actuary

48,220

 

The awards will vest on the third anniversary of their grant, and are subject to an additional retention period of two years, commencing on the awards' vesting date.

 

The vesting of the awards will be subject to the following underpins:

· that the solvency coverage ratio of the Group (being the ratio of the Group's Solvency II net assets to its Solvency Capital Requirement, calculated before the final dividend is paid, expressed as a percentage) is maintained in excess of 140% for the three financial years up to 31 December 2023;

· that the Group has achieved a return on tangible equity (being the ratio of the Group's adjusted profit after tax to its average tangible equity, expressed as a percentage) in excess of 10% for each full reporting period which falls within the three financial years up to 31 December 2023;

· that there has been no material intervention by a regulatory authority either initiated during the three financial years up to 31 December 2023 or related to it, that results in a Group Member being required by the relevant authority to undertake actions or remedial measures; and

· overall Committee discretion.

This notification is made pursuant to Article 19 of the EU Market Abuse Regulation.

 

Additional Information:

Anneka Kingan - Company Secretary

Anneka.kingan@sabre.co.uk 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Geoff Carter

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

261.30 pence

126,539

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

126,539

261.30 pence

 

e)

Date of transaction

21 May 2021

f)

Place of transaction

London Stock Exchange (XLON)

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Anneka Kingan

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Risk Officer and Company Secretary

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

261.30 pence

47,638

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

47,638

261.30 pence

 

e)

Date of transaction

21 May 2021

f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Trevor Webb

2

 

Reason for the notification

 

a)

 

Position/status

 

Claims Director

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

261.30 pence

78,790

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

78,790

261.30 pence

 

e)

Date of transaction

21 May 2021

f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

 

 

 

 

 

 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Adam Westwood

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Financial Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

261.30 pence

59,548

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

59,548

261.30 pence

 

e)

Date of transaction

21 May 2021

f)

Place of transaction

London Stock Exchange (XLON)

 

 

 

PDMR transaction notification

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Matt Wright

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Actuary

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Sabre Insurance Group Plc

b)

 

LEI

 

2138006RXRQ8P8VKGV98

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

A non-transferable conditional award of ordinary shares in the Company under the Sabre 2017 Long-Term Incentive Plan. No consideration will be paid by the PDMR on the grant or vesting of the conditional award.

Identification code

GB00BYWVDP49

b)

 

Nature of the transaction

 

 

Grant of conditional award

c)

 

Price(s) and volume(s)

 

Price per share

Volume

261.30 pence

48,220

d)

Aggregated Information

Volume

Price

 

Volume

Price per share

48,220

261.30 pence

 

e)

Date of transaction

21 May 2021

f)

Place of transaction

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHXFLFLFELBBBL
Date   Source Headline
13th May 20222:24 pmRNSHolding(s) in Company
11th May 20222:27 pmRNSDirector/PDMR Shareholding
26th Apr 20223:17 pmRNSDirector/PDMR Shareholding
26th Apr 20222:21 pmRNSDirector/PDMR Shareholding
14th Apr 20229:01 amRNSHolding(s) in Company
13th Apr 20224:18 pmRNSNotice of AGM
12th Apr 20223:34 pmRNSDirector/PDMR Shareholding
8th Apr 20228:42 amRNSDirector/PDMR Shareholding
1st Apr 20227:13 amRNSDividend Declaration
1st Apr 20227:00 amRNSBoard Appointment
22nd Mar 20227:00 amRNSFinal Results
14th Mar 20221:22 pmRNSDirector Declaration
11th Mar 20221:50 pmRNSDirector/PDMR Shareholding
22nd Feb 20227:00 amRNSNotice of Results
21st Feb 202212:31 pmRNSHolding(s) in Company
11th Feb 202211:34 amRNSDirector/PDMR Shareholding
28th Jan 20227:00 amRNSNew Contract with Freeway Insurance Services Ltd
11th Jan 20222:27 pmRNSDirector/PDMR Shareholding
13th Dec 20211:37 pmRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSAppointment of new additional broker
29th Nov 20217:00 amRNSDirectorate Change
11th Nov 20211:20 pmRNSDirector/PDMR Shareholding
10th Nov 20217:00 amRNSNew Contract as Exclusive Underwriter to MCE
5th Nov 202111:58 amRNSDirector/PDMR Shareholding
14th Oct 20212:27 pmRNSDirector/PDMR Shareholding
14th Oct 202111:41 amRNSDirector/PDMR Shareholding
14th Oct 20217:00 amRNSQ3 Trading Update
12th Oct 202112:06 pmRNSDirector/PDMR Shareholding
12th Oct 202112:02 pmRNSDirector Declaration
7th Oct 20217:00 amRNSNotice of Trading Update
17th Sep 20212:34 pmRNSDirector/PDMR Shareholding
17th Sep 20212:33 pmRNSDirector/PDMR Shareholding
13th Sep 202111:55 amRNSDirector/PDMR Shareholding
11th Aug 20219:51 amRNSDirector/PDMR Shareholding
30th Jul 202110:15 amRNSDirector/PDMR Shareholding
28th Jul 20213:14 pmRNSDirector/PDMR Shareholding
27th Jul 20217:00 amRNSHalf-year Report
13th Jul 202111:24 amRNSDirector/PDMR Shareholding
13th Jul 20217:00 amRNSNotice of Results
6th Jul 202111:00 amRNSHolding(s) in Company
2nd Jul 202112:50 pmRNSDirector/PDMR Shareholding
29th Jun 202111:39 amRNSHolding(s) in Company
22nd Jun 20213:46 pmRNSHolding(s) in Company
11th Jun 202110:53 amRNSDirector/PDMR Shareholding
21st May 20212:28 pmRNSDirector/PDMR Shareholding
21st May 20212:05 pmRNSDirector/PDMR Shareholding
21st May 202110:34 amRNSDirector/PDMR Shareholding
19th May 202112:49 pmRNSHolding(s) in Company
14th May 202111:46 amRNSResults of Annual General Meeting
14th May 20217:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.